Showing results (1-10 of 6,757) with videos related to
Sort By:
Pageof 676
Clinical Therapeutics|October 9, 2001
Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trialJ J CondemiClinical Therapeutics|August 25, 2001
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trialsJ J Caro, M Salas, A WardClinical Therapeutics|July 16, 2002
Statistical comparison of consumer drug expenditures and discretionary purchases to assess drug affordabilityJames A Lee, Patrick L McKercherClinical Therapeutics|August 17, 2002
A retrospective assessment of the effectiveness of fenofibrate 267 mg on high-density lipoprotein cholesterol levels in patients attending a lipid clinicCarel W le Roux, Elaine Murphy, Mary SeedClinical Therapeutics|October 17, 2002
Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension studyGeorge E Dailey, Pharis Mohideen, Fred T FiedorekClinical Therapeutics|June 11, 1999
Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcersN M Agrawal, J Caldwell, A J Kivitz, et al.Clinical Therapeutics|June 11, 1999
Meeting the information needs of drug purchasers: the evolution of formulary submission guidelinesP C LangleyClinical Therapeutics|September 15, 1999
Chlamydia pneumoniae and anti-infective therapy: their role in the pathogenesis and treatment of coronary artery diseaseR Behbahani, C Verme-Gibboney, A M RomanelliClinical Therapeutics|January 25, 2000
Sex-related differences in response of plasma lipids to simvastatin: the Saitama Postmenopausal Lipid Intervention Study. S-POLIS GroupK NakajimaClinical Therapeutics|November 24, 1999
Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failureE J Bastyr, M E Johnson, M E Trautmann, et al.Pageof 676